PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY

Clinical trials for PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY explained in plain language.

Never miss a new study

Get alerted when new PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY trials appear

Sign up with your email to follow new studies for PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New weight loss drug begins first human testing

Disease control Recruiting now

This early-stage study is testing a new drug called IBI3032 for weight management. Researchers will first give single doses to healthy volunteers to check safety, then give multiple doses to people with overweight or obesity over four weeks. The main goal is to see how safe the d…

Matched conditions: PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY

Phase: PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY

Get alerted when new PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY trials appear

New weight loss drug begins first human testing